OLMEVAC H20

OLMEVAC H20 is a combination antihypertensive tablet containing Olmesartan Medoxomil 20 mg, an angiotensin II receptor blocker (ARB), and Hydrochlorothiazide 12.5 mg, a thiazide diuretic. This dual-action medication is prescribed for the management of high blood pressure (hypertension) in adults, particularly when single-drug therapy is not sufficient.

OLMEVAC H20 works by relaxing blood vessels and promoting the excretion of excess salt and water, effectively reducing blood pressure and the risk of cardiovascular complications like heart attacks, strokes, and kidney damage.

Key Features:
✅ Combination of ARB (Olmesartan) + Diuretic (Hydrochlorothiazide)
✅ Controls blood pressure effectively with once-daily dosing
✅ Reduces fluid retention and arterial resistance
✅ Protects heart, brain, and kidneys from damage due to hypertension
✅ Well-tolerated and suitable for long-term use under medical supervision